Antreas Charidimou is a Boston, Massachusetts based neurologist who is specialized in Neurology. Active license number of Antreas Charidimou is 280237 for Neurology in Massachusetts. His current practice location is 725 Albany Street, Shapiro Primary Care, Precepting Room, Boston. Patients can reach him at 617-414-5951 or can fax him at 617-414-9251. Antreas Charidimou is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1053870956. Antreas Charidimou specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Antreas Charidimou speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1053870956
NPI Enumeration Date:
19 Mar, 2019
NPI Last Update On:
09 Jul, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Antreas Charidimou are as mentioned below.
License Number
Specialization
State
Status
280237
Neurology
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Antreas Charidimou 150 S Huntington Ave Fl 6, Boston, Massachusetts
Zip:
02130-4817
Patients can reach Antreas Charidimou at 725 Albany Street, Shapiro Primary Care, Precepting Room, Boston, Massachusetts or can call to book an appointment on 617-414-5951.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.